1-[[1-benzyl-3-(4-chlorophenyl)pyrazol-4-yl]methyl]-4-(2-pyrrolidin-1-ylethyl)piperazine;6,7-dimethoxy-2-phenyl-4-[4-(2-pyrrolidin-1-ylethyl)piperazin-1-yl]quinazoline;1-[[3-methoxy-4-[(4-methylphenyl)methoxy]phenyl]methyl]-4-(2-pyrrolidin-1-ylethyl)piperazine

C79H104ClN13O4 — CID 158954536

IUPAC1-[[1-benzyl-3-(4-chlorophenyl)pyrazol-4-yl]methyl]-4-(2-pyrrolidin-1-ylethyl)piperazine;6,7-dimethoxy-2-phenyl-4-[4-(2-pyrrolidin-1-ylethyl)piperazin-1-yl]quinazoline;1-[[3-methoxy-4-[(4-methylphenyl)methoxy]phenyl]methyl]-4-(2-pyrrolidin-1-ylethyl)piperazine
SMILESCOc1cc(CN2CCN(CCN3CCCC3)CC2)ccc1OCc1ccc(C)cc1.COc1cc2nc(-c3ccccc3)nc(N3CCN(CCN4CCCC4)CC3)c2cc1OC.Clc1ccc(-c2nn(Cc3ccccc3)cc2CN2CCN(CCN3CCCC3)CC2)cc1
InChIInChI=1S/C27H34ClN5.C26H33N5O2.C26H37N3O2/c28-26-10-8-24(9-11-26)27-25(22-33(29-27)20-23-6-2-1-3-7-23)21-32-18-16-31(17-19-32)15-14-30-12-4-5-13-30;1-32-23-18-21-22(19-24(23)33-2)27-25(20-8-4-3-5-9-20)28-26(21)31-16-14-30(15-17-31)13-12-29-10-6-7-11-29;1-22-5-7-23(8-6-22)21-31-25-10-9-24(19-26(25)30-2)20-29-17-15-28(16-18-29)14-13-27-11-3-4-12-27/h1-3,6-11,22H,4-5,12-21H2;3-5,8-9,18-19H,6-7,10-17H2,1-2H3;5-10,19H,3-4,11-18,20-21H2,1-2H3
InChIKeyJLVNIHIOXKLNMF-UHFFFAOYSA-N
MW1335.24 g/mol
LogP11.79
Rot. Bonds24

About 1-[[1-benzyl-3-(4-chlorophenyl)pyrazol-4-yl]methyl]-4-(2-pyrrolidin-1-ylethyl)piperazine;6,7-dimethoxy-2-phenyl-4-[4-(2-pyrrolidin-1-ylethyl)piperazin-1-yl]quinazoline;1-[[3-methoxy-4-[(4-methylphenyl)methoxy]phenyl]methyl]-4-(2-pyrrolidin-1-ylethyl)piperazine

1-[[1-benzyl-3-(4-chlorophenyl)pyrazol-4-yl]methyl]-4-(2-pyrrolidin-1-ylethyl)piperazine;6,7-dimethoxy-2-phenyl-4-[4-(2-pyrrolidin-1-ylethyl)piperazin-1-yl]quinazoline;1-[[3-methoxy-4-[(4-methylphenyl)methoxy]phenyl]methyl]-4-(2-pyrrolidin-1-ylethyl)piperazine (PubChem CID 158954536) has the molecular formula C79H104ClN13O4 and a molecular weight of 1335.24 g/mol. Its IUPAC name is 1-[[1-benzyl-3-(4-chlorophenyl)pyrazol-4-yl]methyl]-4-(2-pyrrolidin-1-ylethyl)piperazine;6,7-dimethoxy-2-phenyl-4-[4-(2-pyrrolidin-1-ylethyl)piperazin-1-yl]quinazoline;1-[[3-methoxy-4-[(4-methylphenyl)methoxy]phenyl]methyl]-4-(2-pyrrolidin-1-ylethyl)piperazine.

Molecular Properties

Compound Name1-[[1-benzyl-3-(4-chlorophenyl)pyrazol-4-yl]methyl]-4-(2-pyrrolidin-1-ylethyl)piperazine;6,7-dimethoxy-2-phenyl-4-[4-(2-pyrrolidin-1-ylethyl)piperazin-1-yl]quinazoline;1-[[3-methoxy-4-[(4-methylphenyl)methoxy]phenyl]methyl]-4-(2-pyrrolidin-1-ylethyl)piperazine
PubChem CID158954536
Molecular FormulaC79H104ClN13O4
Molecular Weight1335.24 g/mol
Exact Mass1333.80
IUPAC Name1-[[1-benzyl-3-(4-chlorophenyl)pyrazol-4-yl]methyl]-4-(2-pyrrolidin-1-ylethyl)piperazine;6,7-dimethoxy-2-phenyl-4-[4-(2-pyrrolidin-1-ylethyl)piperazin-1-yl]quinazoline;1-[[3-methoxy-4-[(4-methylphenyl)methoxy]phenyl]methyl]-4-(2-pyrrolidin-1-ylethyl)piperazine
SMILESCOc1cc(CN2CCN(CCN3CCCC3)CC2)ccc1OCc1ccc(C)cc1.COc1cc2nc(-c3ccccc3)nc(N3CCN(CCN4CCCC4)CC3)c2cc1OC.Clc1ccc(-c2nn(Cc3ccccc3)cc2CN2CCN(CCN3CCCC3)CC2)cc1
InChIInChI=1S/C27H34ClN5.C26H33N5O2.C26H37N3O2/c28-26-10-8-24(9-11-26)27-25(22-33(29-27)20-23-6-2-1-3-7-23)21-32-18-16-31(17-19-32)15-14-30-12-4-5-13-30;1-32-23-18-21-22(19-24(23)33-2)27-25(20-8-4-3-5-9-20)28-26(21)31-16-14-30(15-17-31)13-12-29-10-6-7-11-29;1-22-5-7-23(8-6-22)21-31-25-10-9-24(19-26(25)30-2)20-29-17-15-28(16-18-29)14-13-27-11-3-4-12-27/h1-3,6-11,22H,4-5,12-21H2;3-5,8-9,18-19H,6-7,10-17H2,1-2H3;5-10,19H,3-4,11-18,20-21H2,1-2H3
InChIKeyJLVNIHIOXKLNMF-UHFFFAOYSA-N
XLogP11.79
TPSA109.68 Ų
H-Bond Donors
H-Bond Acceptors17
Rotatable Bonds24
Heavy Atoms97
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001335.24
LogP ≤ 511.79
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1017

Analyze 1-[[1-benzyl-3-(4-chlorophenyl)pyrazol-4-yl]methyl]-4-(2-pyrrolidin-1-ylethyl)piperazine;6,7-dimethoxy-2-phenyl-4-[4-(2-pyrrolidin-1-ylethyl)piperazin-1-yl]quinazoline;1-[[3-methoxy-4-[(4-methylphenyl)methoxy]phenyl]methyl]-4-(2-pyrrolidin-1-ylethyl)piperazine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-[[1-benzyl-3-(4-chlorophenyl)pyrazol-4-yl]methyl]-4-(2-pyrrolidin-1-ylethyl)piperazine;6,7-dimethoxy-2-phenyl-4-[4-(2-pyrrolidin-1-ylethyl)piperazin-1-yl]quinazoline;1-[[3-methoxy-4-[(4-methylphenyl)methoxy]phenyl]methyl]-4-(2-pyrrolidin-1-ylethyl)piperazine?
The IUPAC name of 1-[[1-benzyl-3-(4-chlorophenyl)pyrazol-4-yl]methyl]-4-(2-pyrrolidin-1-ylethyl)piperazine;6,7-dimethoxy-2-phenyl-4-[4-(2-pyrrolidin-1-ylethyl)piperazin-1-yl]quinazoline;1-[[3-methoxy-4-[(4-methylphenyl)methoxy]phenyl]methyl]-4-(2-pyrrolidin-1-ylethyl)piperazine (CID 158954536) is 1-[[1-benzyl-3-(4-chlorophenyl)pyrazol-4-yl]methyl]-4-(2-pyrrolidin-1-ylethyl)piperazine;6,7-dimethoxy-2-phenyl-4-[4-(2-pyrrolidin-1-ylethyl)piperazin-1-yl]quinazoline;1-[[3-methoxy-4-[(4-methylphenyl)methoxy]phenyl]methyl]-4-(2-pyrrolidin-1-ylethyl)piperazine.
What is the SMILES notation for 1-[[1-benzyl-3-(4-chlorophenyl)pyrazol-4-yl]methyl]-4-(2-pyrrolidin-1-ylethyl)piperazine;6,7-dimethoxy-2-phenyl-4-[4-(2-pyrrolidin-1-ylethyl)piperazin-1-yl]quinazoline;1-[[3-methoxy-4-[(4-methylphenyl)methoxy]phenyl]methyl]-4-(2-pyrrolidin-1-ylethyl)piperazine?
The canonical SMILES for 1-[[1-benzyl-3-(4-chlorophenyl)pyrazol-4-yl]methyl]-4-(2-pyrrolidin-1-ylethyl)piperazine;6,7-dimethoxy-2-phenyl-4-[4-(2-pyrrolidin-1-ylethyl)piperazin-1-yl]quinazoline;1-[[3-methoxy-4-[(4-methylphenyl)methoxy]phenyl]methyl]-4-(2-pyrrolidin-1-ylethyl)piperazine is COc1cc(CN2CCN(CCN3CCCC3)CC2)ccc1OCc1ccc(C)cc1.COc1cc2nc(-c3ccccc3)nc(N3CCN(CCN4CCCC4)CC3)c2cc1OC.Clc1ccc(-c2nn(Cc3ccccc3)cc2CN2CCN(CCN3CCCC3)CC2)cc1.
What is the InChIKey of 1-[[1-benzyl-3-(4-chlorophenyl)pyrazol-4-yl]methyl]-4-(2-pyrrolidin-1-ylethyl)piperazine;6,7-dimethoxy-2-phenyl-4-[4-(2-pyrrolidin-1-ylethyl)piperazin-1-yl]quinazoline;1-[[3-methoxy-4-[(4-methylphenyl)methoxy]phenyl]methyl]-4-(2-pyrrolidin-1-ylethyl)piperazine?
The InChIKey is JLVNIHIOXKLNMF-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H34ClN5.C26H33N5O2.C26H37N3O2/c28-26-10-8-24(9-11-26)27-25(22-33(29-27)20-23-6-2-1-3-7-23)21-32-18-16-31(17-19-32)15-14-30-12-4-5-13-30;1-32-23-18-21-22(19-24(23)33-2)27-25(20-8-4-3-5-9-20)28-26(21)31-16-14-30(15-17-31)13-12-29-10-6-7-11-29;1-22-5-7-23(8-6-22)21-31-25-10-9-24(19-26(25)30-2)20-29-17-15-28(16-18-29)14-13-27-11-3-4-12-27/h1-3,6-11,22H,4-5,12-21H2;3-5,8-9,18-19H,6-7,10-17H2,1-2H3;5-10,19H,3-4,11-18,20-21H2,1-2H3.
What are the key properties of 1-[[1-benzyl-3-(4-chlorophenyl)pyrazol-4-yl]methyl]-4-(2-pyrrolidin-1-ylethyl)piperazine;6,7-dimethoxy-2-phenyl-4-[4-(2-pyrrolidin-1-ylethyl)piperazin-1-yl]quinazoline;1-[[3-methoxy-4-[(4-methylphenyl)methoxy]phenyl]methyl]-4-(2-pyrrolidin-1-ylethyl)piperazine?
1-[[1-benzyl-3-(4-chlorophenyl)pyrazol-4-yl]methyl]-4-(2-pyrrolidin-1-ylethyl)piperazine;6,7-dimethoxy-2-phenyl-4-[4-(2-pyrrolidin-1-ylethyl)piperazin-1-yl]quinazoline;1-[[3-methoxy-4-[(4-methylphenyl)methoxy]phenyl]methyl]-4-(2-pyrrolidin-1-ylethyl)piperazine has a molecular weight of 1335.24 g/mol, XLogP of 11.79, 24 rotatable bonds, 0 hydrogen bond donors, and 17 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[[1-benzyl-3-(4-chlorophenyl)pyrazol-4-yl]methyl]-4-(2-pyrrolidin-1-ylethyl)piperazine;6,7-dimethoxy-2-phenyl-4-[4-(2-pyrrolidin-1-ylethyl)piperazin-1-yl]quinazoline;1-[[3-methoxy-4-[(4-methylphenyl)methoxy]phenyl]methyl]-4-(2-pyrrolidin-1-ylethyl)piperazine is sourced from PubChem (CID 158954536), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).